Global Hyoscyamine Sulfate Injection Market Size, Share, Growth, Trends, Analysis and Forecast – 2028

The global hyoscyamine sulfate injection market is anticipated to grow at a considerable CAGR 2% during the forecast period (2022-2028). The market growth is attributed to the rising geriatric population across the globe. It leads to an increase in incontinence episodes among elderly patients. The strict regulations imposed on the healthcare industry may hamper the growth of the market. The hyoscyamine sulfate injections are used for the treatment of intestinal spasms, peptic ulcer disease, and urinary retention. It also is used to reduce fluid in various areas such as the respiratory tract, pharynx, larynx, and bronchi. In addition, it is effective in treating certain conditions that cause excessive sweating.

The drug is not approved by the FDA, hyoscyamine has no official prescriptions. Intravenous Hysocyamine has been used to reduce diarrhea, reduce pain and pancreatic discharge, facilitate the detection of the gastrointestinal tract, treat anticholinesterase toxicity, treat certain partial heart failure, improve kidney appearance, and relieve biliary. Intravenous hyoscyamine is also used before surgery to reduce oral and respiratory failure. Oral hyoscyamine is used to treat functional bowel disorders, relieve biliary symptoms and renal colic, as well as relief of symptoms of acute rhinitis.

Additionally, thenorth american region is expected to have the highest market share due to the presence of pharmaceutical companies based in the region. The growth is due to the strict rules imposed on health care facilities that create the need to inject hyoscyamine sulfate, the availability of highly skilled staff, and the support of major drug manufacturers operating in the region who provide a variety of treatments for some of the factors that are driving the growth of the market during the forecasted period.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape-Alaven Pharmaceutical, BPI Labs, Meda AB, Mylan NV, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Hyoscyamine Sulfate Injection Market Report by Segment

By Type

• 5mg/ml
• 1mg/2ml

By Application

• Hospital
• Clinics
• Recovery Center

Global Hyoscyamine Sulfate Injection Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa